![Ivan Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Møller
Directeur des opérations chez
ZEALAND PHARMA A/S
Fortune : 4 M $ au 31/05/2026
Profil
Ivan M.
Møller currently works at Zealand Pharma A, as Chief Operating Officer & Executive Vice President.
Mr. Møller also formerly worked at PolyPeptide Laboratories A, as Head-Production from 2002 to 2003, Novartis AG, as Global Head-Operations Management from 2017 to 2018, and Novartis Corp., as Vice President & Head-External Supply Organization from 2017 to 2018.
Mr. Møller received his graduate degree from Technical University of Denmark and Masters Business Admin degree in 2005 from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0,11% | 31/12/2025 | 78 587 ( 0,11% ) | 4 M $ | 31/05/2026 |
Postes actifs de Ivan Møller
| Sociétés | Poste | Début |
|---|---|---|
| ZEALAND PHARMA A/S | Directeur des opérations | 01/03/2018 |
Anciens postes connus de Ivan Møller
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2018 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/01/2018 |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Corporate Officer/Principal | 01/01/2003 |
Formation de Ivan Møller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
